Marco Maria Germani

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer

Élena Elez, Javier Ros, J. Fernández et al. · Nature Medicine · 2022 · 103 citations · Full text

Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications

Roberto Moretto, Andrew Elliott, Jian Zhang et al. · JNCI Journal of the National Cancer Institute · 2021 · 72 citations · Full text

Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors

Paolo Manca, Francesca Corti, Rossana Intini et al. · European Journal of Cancer · 2023 · 50 citations · Full text

Medicine, Immune Checkpoint Inhibitors, Immunology +8

<i>EGFR</i>Amplification in Metastatic Colorectal Cancer

Giovanni Randon, Rona Yaeger, Jaclyn F. Hechtman et al. · JNCI Journal of the National Cancer Institute · 2021 · 32 citations · Full text

Negative Ultraselection of Patients With <i>RAS</i>/<i>BRAF</i> Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy

Giovanni Randon, Giulia Maddalena, Marco Maria Germani et al. · JCO Precision Oncology · 2022 · 28 citations · Full text